N,N-BIS((2R)-3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOL-2-YL)-2-((1H-IMIDAZOL-1-YLCARBONYL)OXY)PROPYL)-4-(3-OXO-4-MORPHOLINYL)ANILINE
UNII R7FUH5TVN4
Substance Identification & Data
This profile provides standardized clinical and technical data for N,n-bis((2r)-3-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)-2-((1h-imidazol-1-ylcarbonyl)oxy)propyl)-4-(3-oxo-4-morpholinyl)aniline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R7FUH5TVN4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2097255-05-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C40H34N8O10 PICQBDSICPMTCI-FQLXRVMXSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N,n-bis((2r)-3-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)-2-((1h-imidazol-1-ylcarbonyl)oxy)propyl)-4-(3-oxo-4-morpholinyl)aniline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.